T40025 |
Pomalidomide-PEG2-CO2H
|
2140807-17-4
|
99.25%
|
|
Pomalidomide-PEG2-CO2H is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a 2-unit PEG linker.
|
T40023 |
Pomalidomide-PEG3-CO2H
|
2138440-82-9
|
99.05%
|
|
Pomalidomide-PEG3-CO2H (Thalidomide-NH-PEG3-propionic acid) is a synthesized E3 ligase ligand-linker conjugate. Pomalidomide-PEG3-CO2H incorporates the Thalidomi...
|
T18807 |
Thalidomide-NH-C4-NH-Boc
|
2093388-52-2
|
98.87%
|
|
Thalidomide-NH-C4-NH-Boc is a synthesized conjugate used in PROTAC technology, combining a Thalidomide-based cereblon ligand with a linker.
|
T40010 |
Pomalidomide-C9-COOH
|
2243000-24-8
|
98.86%
|
|
Pomalidomide-C9-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology...
|
T40013 |
Thalidomide-O-CH2CONH-CH2COOH
|
T40013
|
98.86%
|
|
Thalidomide-O-CH2CONH-CH2COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based CRBN ligand and linker used in PROTAC te...
|
T40012 |
Thalidomide-CH2CONH-C2-COOH
|
T40012
|
98.84%
|
|
Thalidomide-CH2CONH-C2-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based CRBN ligand and linker used in PROTAC tech...
|
T40011 |
Thalidomide-CH2CONH-C3-COOH
|
T40011
|
98.38%
|
|
Thalidomide-CH2CONH-C3-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based CRBN ligand and linker used in PROTAC tech...
|
T40009 |
Pomalidomide-C4-COOH
|
2225940-48-5
|
98.10%
|
|
Pomalidomide-C4-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology...
|
T5821 |
BC-1215
|
1507370-20-8
|
98%
|
|
BC-1215 is an inhibitor of F-box protein 3 (FBXO3, a ubiquitin E3 ligase component, IC50=0.9 μg/mL for IL-1β release).
|
T8232 |
PEG6-(CH2CO2H)2
|
77855-76-6
|
98%
|
|
PEG6-(CH2CO2H)2 is a symmetric PEG PROTAC linker.
|
T40007 |
Pomalidomide-C5-COOH
|
T40007
|
97.98%
|
|
Pomalidomide-C5-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology...
|
T40015 |
Pomalidomide-PEG2-NH2 hydrochloride
|
T40015
|
97.95%
|
|
Pomalidomide-PEG2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PR...
|
T8412 |
(S,R,S)-AHPC
|
1448297-52-6
|
97.87%
|
|
(S,R,S)-AHPC (VH032-NH2) is the VH032-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein. (S,R,S)-AHPC is potential useful for the t...
|
T40005 |
Pomalidomide-C2-COOH
|
T40005
|
97.65%
|
|
Pomalidomide-C2-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology...
|
T17922 |
(S,R,S)-AHPC-PEG3-NH2 hydrochloride
|
2097971-11-2
|
97.58%
|
|
(S,R,S)-AHPC-PEG3-NH2 hydrochloride (E3 ligase Ligand-Linker Conjugates 5) is an E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC-based VHL ligan...
|
T18816 |
Thalidomide-O-amido-C6-NH2 hydrochloride
|
2376990-31-5
|
97.33%
|
|
Thalidomide-O-amido-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate, integrating a Thalidomide-based cereblon ligand with a linker, suita...
|
T40024 |
Pomalidomide-PEG1-CO2H
|
2139348-60-8
|
97.2%
|
|
Pomalidomide-PEG1-CO2H is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a 2-unit PEG linker.
|
T40006 |
Pomalidomide-CH2CONH-C2-COOH
|
T40006
|
96.95%
|
|
Pomalidomide-CH2CONH-C2-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC te...
|
T40014 |
Pomalidomide-C4-OH
|
T40014
|
96.61%
|
|
Pomalidomide-C4-OH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
|
T40000 |
Pomalidomide-C3-I
|
T40000
|
96.05%
|
|
Pomalidomide-C3-I is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
|